HEALTHEURACTIV
EMA oversight sparks friction in medical devices overhaul
Italy and Czechia are opposing a proposed expansion of the European Medicines Agency's decision-making role in the overhaul of medical devices regulations. The move has sparked friction among stakeholders involved in the regulatory process.
Related Signal
Adjacent reporting
- Trump Pivots on AI Regulation, Worker Ousted by DOGE Runs for Office, and Hantavirus Explained
- Here’s how far the Trump administration’s ‘startling turn’ on AI regulation might go
- STAT+: EU and US advisers split over AstraZeneca breast cancer drug
- The White House is considering tighter regulation of new AI models
- A Republican revolt over AI is taking shape in the US